Results 181 to 190 of about 8,660,824 (403)
Background: The biosafety of gene therapy products remains a major challenge to their introduction into the clinic. In particular, the problem of immunogenicity of viral vectors is the focus of attention.
Andrei Izmailov +11 more
doaj +1 more source
A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density [PDF]
Anja Rudolph +39 more
openalex +1 more source
Gene therapy is a new modality of treatment in which a gene is used to modify or add new biochemical properties to a patient's target cells with therapeutics purposes. Currently, this experimental therapy is under intensive development as an alternative to treat cancer, because it is possible that this therapy may generate a higher antineoplastic ...
Augusto, Rojas-Martínez +4 more
openaire +1 more source
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian +10 more
wiley +1 more source
KRONİK AĞRIDA GENETİK TEDAVİ VE HEMŞİRENİN ROLÜ
Kronik ağrı, insidansı yüksek olan önemli sağlık sorunlarından biridir. Kronik ağrı bireyin yaşam kalitesini olumsuz etkilemekte, immun sistemi baskılama, anksiyete, depresyon ve intihara eğilim gibi ciddi komplikasyonlara yol açmaktadır.
Kübra Yılmaz, Sema Koçaşlı
doaj
Aspects of genetic imprinting: implications, syndromes and therapies [PDF]
Nada A Hassan
openalex +1 more source
Neuroprotective therapies in glaucoma: II. Genetic nanotechnology tools [PDF]
Nafiseh Nafissi, Marianna Földvári
openalex +1 more source
A comprehensive genomic and proteomic analysis of cervical cancer revealed STK11 and STX3 as a potential biomarkers of chemoradiation resistance. Our study demonstrated EGFR as a therapeutic target, paving the way for precision strategies to overcome treatment failure and the DNA repair pathway as a critical mechanism of resistance.
Janani Sambath +13 more
wiley +1 more source
YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma
The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy +9 more
wiley +1 more source

